Tullinge, Sweden

Peter G Zaphiropoulos

Average Co-Inventor Count = 10.3

ph-index = 1

Forward Citations = 11(Granted Patents)

Forward Citations (Not Self Cited) = 11(Sep 21, 2024)


Years Active: 2003-2008

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: The Innovative Mind of Peter G Zaphiropoulos

Introduction: Peter G Zaphiropoulos, located in Tullinge, Sweden, is a prominent inventor known for his significant contributions to the field of cancer research. With a total of three patents, his work primarily focuses on genetic factors related to basal cell carcinoma. His groundbreaking discoveries are pivotal in understanding tumor suppressor genes and their roles in cancer development.

Latest Patents: One of Zaphiropoulos' latest patents revolves around the "Basal cell carcinoma tumor suppressor protein." This invention provides insights into a tumor suppressor gene whose inactivation is a causal factor in nevoid basal cell carcinoma syndrome and various sporadic basal cell carcinomas. Additionally, his work includes the "Component in the hedgehog signalling pathway," which introduces a novel human patched-like gene (PTCH2). For the first time, PTCH2 has been cloned and sequenced, identifying several alternatively spliced mRNA forms, along with the protein encoded by PTCH2 and its functional analogues and variants.

Career Highlights: Zaphiropoulos has made remarkable strides in his career, contributing not only through his patents but also by collaborating with various esteemed organizations. He has worked with the United States of America as represented by the Department of Health and Human Services, as well as Karolinska Innovations AB, enhancing the scientific community's understanding of genetic factors in cancer.

Collaborations: Throughout his career, Zaphiropoulos has collaborated with notable coworkers such as Anne Birgitte Unden and Michael C Dean. These partnerships illustrate the collaborative nature of scientific research and the importance of teamwork in advancing knowledge in the field of medicine.

Conclusion: Peter G Zaphiropoulos exemplifies the innovation and dedication necessary for impactful scientific research. His patents highlight significant advancements in understanding cancer biology, specifically related to basal cell carcinoma. Through his continued efforts and collaborations, he is contributing to the development of potential therapeutic avenues, offering hope for future treatments in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…